Work

Nephrotoxicity risks of colistin-combination therapy: a USFDA adverse event reporting system analysis using disproportionality and interaction assessment

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2025.2499672

Author: Kannan Sridharan

Institution: Arabian Gulf University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409843746

FWCI: 1.368

Cites: 46

Cited by: 1

Related to: 10